Conning Inc. Novo Nordisk A S Transaction History

Conning Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$90.94 - $199.54 $128,771 - $282,548	1,416 Added 100.0%	2,832 $257,000
Q2 2023 Jul 21, 2023	SELL	$155.98 - $172.65 $96,707 - $107,043	-620 Reduced 30.45%	1,416 $229,000
Q3 2022 Oct 28, 2022	SELL	$95.28 - $116.93 $119,481 - $146,630	-1,254 Reduced 38.12%	2,036 $203,000
Q2 2022 Jul 20, 2022	SELL	$103.24 - $121.81 $63,492 - $74,913	-615 Reduced 15.75%	3,290 $367,000
Q4 2021 Jan 27, 2022	SELL	$95.88 - $117.08 $605,002 - $738,774	-6,310 Reduced 61.77%	3,905 $437,000
Q3 2021 Nov 05, 2021	BUY	$84.42 - $106.62 $510,065 - $644,198	6,042 Added 144.79%	10,215 $981,000
Q2 2020 Aug 07, 2020	SELL	$58.54 - $67.94 $24,411 - $28,330	-417 Reduced 9.08%	4,173 $273,000
Q4 2019 Jan 29, 2020	BUY	$49.86 - $58.26 $228,857 - $267,413	4,590 New	4,590 $266,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

Stay updated on Conning Inc. with notifications on news.